granted
on 17 Nov 2023
Last Applicant/ Owned by
333 Oyster Point Boulevard
South San Francisco
CA
94080
Serial Number
97341671 filed on 31st Mar 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIO"
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials "BIO" Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases Color is not claimed as a feature of the mark. Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurologicRead More
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
No 97341671
No Service Mark
No 131254999512
No
No
No
No
No
No
No
No
26.03.01 -
Ovals as carriers and single line borders
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the letters "NGM BIO" within a horizontal oval which contains a swooping stripe going through it on the right side.
| Status Date | Action Taken |
|---|---|
| 21st Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
| 17th Nov 2023 | SOU EXTENSION 1 FILED |
| 17th Nov 2023 | SOU EXTENSION 1 GRANTED |
| 06th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 11th Apr 2023 | PUBLISHED FOR OPPOSITION |
| 11th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Mar 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 02th Feb 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
